HT
LEGN icon

Headlands Technologies’s Legend Biotech LEGN Stock Holding History

Headlands Technologies’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$693K Sell
23,995
-25,433
-51% -$686K 0.07% 335
2026
Q1 		$894K Buy
49,428
+14,686
+42% +$280K 0.1% 230
2025
Q4 		$755K Buy
+34,742
New +$995K 0.06% 316
2025
Q1 		– Sell
-11,935
Closed -$388K – 1356
2024
Q4 		$388K Buy
11,935
+11,373
+2,024% +$471K 0.04% 396
2024
Q3 		$27.4K Buy
+562
New +$29.9K ﹤0.01% 902

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Headlands Technologies's LEGN Position: Q2 2026 in Review

Headlands Technologies reduced its Legend Biotech (LEGN) stake by 51% in Q2 2026, selling an estimated $686K and leaving 23,995 shares worth $693K. The position accounts for 0.07% of the portfolio, ranked #335.

Headlands Technologies first reported a position in LEGN in Q3 2024 and has held it in 5 quarters since. The position peaked at $894K in Q1 2026. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Headlands Technologies held 23,995 shares of Legend Biotech worth $693K as of Q2 2026.
  • Headlands Technologies sold 25,433 Legend Biotech shares in Q2 2026, an estimated $686K.
  • Legend Biotech made up 0.07% of Headlands Technologies's portfolio in Q2 2026, its #335 holding.
  • Headlands Technologies first reported a position in Legend Biotech in Q3 2024 and has held it in 5 quarters since.
  • Headlands Technologies's Legend Biotech position peaked at $894K in Q1 2026.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.